Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how new preclinical data continues to support the potential of Cyxone’s investigational plant-derived peptide T20K for the treatment of multiple sclerosis (MS).

Price also reads the column by Jamie Hughes, A Life in Letters, “When Is a Wall Not Just a Wall?”.

===================================

Are you interested in learning more about multiple sclerosis? If so, please visit:

https://multiplesclerosisnewstoday.com/

=====================================

To join in on conversations regarding multiple sclerosis, please visit:

https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how a population-based study tied infectious mononucleosis (EBV) in childhood or adolescence to a roughly 2-to-3 times greater MS risk as adult. 

Also, Price Wooldridge, reads the column by John Connor, Fall Down, Get Up Again, “An Interview With My Primary Carer”.

===================================

Are you interested in learning more about multiple sclerosis? If so, please visit:

https://multiplesclerosisnewstoday.com/

=====================================

To join in on conversations regarding multiple sclerosis, please visit:

https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how mice kept for two weeks at 10 C (50 F) showed lesser MS-like symptoms and inflammation than others, likely due to body's response to cold.

Price also reads “Aquatic Therapy for Chronic Back Pain”, column by Ed Tobias.

===================================

Are you interested in learning more about multiple sclerosis? If so, please visit:

https://multiplesclerosisnewstoday.com/

=====================================

To join in on conversations regarding multiple sclerosis, please visit:

https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how Owlytics’ provided scientific evidence that the smartwatch may be used as a measure of response to a treatment in a clinical trial.

Plus, reads “Curing Headaches, Pain, and Stress, One Gizmo at a Time”, a column by Jamie Hughes.

===================================

Are you interested in learning more about multiple sclerosis? If so, please visit:

https://multiplesclerosisnewstoday.com/

=====================================

To join in on conversations regarding multiple sclerosis, please visit:

https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses treatment with mesenchymal stem cells or MSCs in adults with active MS failed to significantly reduce brain inflammation, trial data show. Plus, reads the column by John Connor, Fall Down, Get Up Again, “There’s a New Primary Carer in Town”.

===================================

Are you interested in learning more about multiple sclerosis? If so, please visit:

https://multiplesclerosisnewstoday.com/

=====================================

To join in on conversations regarding multiple sclerosis, please visit:

https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses an early MRI measures of brain atrophy and serum NfL levels may accurately predict progression for relapsing forms of MS, a study suggests.

Also, Price reads “More Answers About COVID-19 Vaccines and MS”, a column by Ed Tobias.

===================================

Are you interested in learning more about multiple sclerosis? If so, please visit:

https://multiplesclerosisnewstoday.com/

=====================================

To join in on conversations regarding multiple sclerosis, please visit:

https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how younger RRMS patients (under 50) whose active disease fails to respond to DMT use might consider a patient-derived bone marrow transplant.

Also, Price reads "“Kintsugi Reminds Me That Living With MS Isn’t Something to Hide”", a column by Jamie Hughes.

===================================

Are you interested in learning more about multiple sclerosis? If so, please visit:

https://multiplesclerosisnewstoday.com/

=====================================

To join in on conversations regarding multiple sclerosis, please visit:

https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how Innodem and Novartis Canada are launching a clinical trial to evaluate biomarker eye-tracking technology for monitoring MS progression.

Plus, Price reads “My Coffee Cup Runneth Over, Plus a Darned Interruption”, a column by John Connor.

===================================

Are you interested in learning more about multiple sclerosis? If so, please visit:

https://multiplesclerosisnewstoday.com/

=====================================

To join in on conversations regarding multiple sclerosis, please visit:

https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how treatment with the anti-malaria medication hydroxychloroquine may help slow disability progression among people with PPMS.

Price Wooldridge, reads the column by Jamie Hughes, A Life in Letters, “Just Put One Foot in Front of the Other”.

===================================

Are you interested in learning more about multiple sclerosis? If so, please visit:

https://multiplesclerosisnewstoday.com/

=====================================

To join in on conversations regarding multiple sclerosis, please visit:

https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how people in Australia with multiple sclerosis (MS) and certain other medical conditions will have access to new and expanded medications — including Kesimpta — now listed on the Pharmaceutical Benefits Scheme (PBS).

Plus, Price reads the column by Jamie Hughes, A Life in Letters, “Celebrity or Not, You Matter to the MS Community”.

===================================

Are you interested in learning more about multiple sclerosis? If so, please visit:

https://multiplesclerosisnewstoday.com/

=====================================

To join in on conversations regarding multiple sclerosis, please visit:

https://multiplesclerosisnewstoday.com/forums/